Radiolabeling of neurotensin agonist and antagonist with 177Lu: bioafinity of 177Lu-DOTA-NT and 177Lu-DOTA-SR48692 to neurotensin receptors

被引：1
|
作者：
Lungu, Valeria [1 ]
机构：
[1] Horia Hulbei Natl Inst Phys & Nucl Engn, Magurele, Ilfov County, Romania
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2010年 / 37卷 / 06期
关键词：
D O I：
10.1016/j.nucmedbio.2010.04.142
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：691 / 691
页数：1
相关论文
共 50 条
  • [31] Development of radiopharmaceuticals to target neurotensin receptors based on 68Ga and 177Lu
    Niculae, Dana
    Mihon, Mirela
    Leonte, Radu
    Silisteanu, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [32] Influence of DOTA chelators on radioimmunotherapy of 177Lu-DOTA-Rituximab
    Wojdowska, Wioletta
    Karczmarczyk, Urszula
    Balogh, Lajos
    Mikolajczak, Renata
    Maurin, Michal
    Postenyi, Zita
    Kovacs-Haasz, Veronika
    Polyak, Andras
    Garnuszek, Piotr
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S368 - S368
  • [33] Bioaffinity testing of 68Ga/177Lu-DOTA-Neurotensin and neurotensin fragments as teranostic agent in colon cancer
    Niculae, D.
    Draganescu, D.
    Min, E. A.
    Raicu, A.
    Chilug, L.
    Manda, G.
    Leonte, R. A.
    Manea, I.
    Costache, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S555 - S555
  • [34] DOTA-conjugation and 177Lu-DOTA-radiolabeling optimizations of IgG4 antibodies
    Jha, P.
    Berglund, H.
    Shojai, T. M.
    Mortensen, A. C. L.
    Nestor, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S676 - S677
  • [35] Maintaining radiochemical purity of [177Lu]Lu-DOTA-PSMA-617 for PRRT by reducing radiolysis
    Rory M. S. de Zanger
    Ho Sze Chan
    Wouter A. P. Breeman
    Erik de Blois
    Journal of Radioanalytical and Nuclear Chemistry, 2019, 321 : 285 - 291
  • [36] A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE
    Klosinska, Martyna
    Kolodziej, Joanna
    Mroz, Adrianna
    Madra, Weronika
    Kaminski, Grzegorz
    NUCLEAR MEDICINE REVIEW, 2024, 27 : 39 - 41
  • [37] Maintaining radiochemical purity of [177Lu]Lu-DOTA-PSMA-617 for PRRT by reducing radiolysis
    de Zanger, Rory M. S.
    Chan, Ho Sze
    Breeman, Wouter A. P.
    de Blois, Erik
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2019, 321 (01) : 285 - 291
  • [38] Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China
    Liu, Fei
    Li, Panli
    Xu, Junyan
    Zhang, Jianping
    Xu, Xiaoping
    Chen, Zhihao
    Qiao, Ying
    Liang, Yun
    Chen, Jie
    Song, Shaoli
    EJNMMI RESEARCH, 2024, 14 (01):
  • [39] Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics
    Cheng, Jordan
    Zink, Joke
    O'Neill, Edward
    Cornelissen, Bart
    Nonnekens, Julie
    Livieratos, Lefteris
    Terry, Samantha Y. A.
    EJNMMI RESEARCH, 2024, 14 (01):
  • [40] On the preparation of a therapeutic dose of 177Lu-labeled DOTA-TATE using indigenously produced 177Lu in medium flux reactor
    Das, Tapas
    Chakraborty, Sudipta
    Banerjee, Sharmila
    Venkatesh, Meera
    APPLIED RADIATION AND ISOTOPES, 2007, 65 (03) : 301 - 308
12345